Search results

15 items
  1. Informal Drug Policy Dialogue 2006 Bern

    06 November 2006 - Event

    The third Informal Drug Policy Dialogue was co-hosted by the Swiss Federal Office of Public Health. Participants, most of whom are actively involved in policy, included over forty people from 21 countries, six inter-governmental organisations, five international NGOs and several academics. The two-day dialogue had four sessions focused on (1) the effectiveness of law enforcement in supply reduction, (2) recent developments around HIV/AIDS and harm reduction, (3) Bolivia and legal options for the coca leaf and (4) preparations for the 2008 UNGASS Review. In addition, participants were invited to visit the Bern city drug injection facility, where managers explained how the facility functioned and gave a guided tour of the premises.

     

  2. Just Say Coca

    Jimmy Langman
    30 October 2006
    Other news

    Bolivian president Evo Morales recently implored the United Nations to give the coca leaf a new life. A former coca farmer himself, Morales asked the General Assembly to focus on coca's possible future as the raw material for a lucrative consumer-goods industry--not its nefarious present, as the source of the international cocaine trade. "This is the coca leaf, it is green, and not white like cocaine," Morales lectured, waving one limp little leaf at the hall of surprised dignitaries. Why, he demanded, is it "legal for Coca-Cola" but not other consumer or medicinal uses?

  3. 'Paco' Under Scrutiny

    • Transnational Institute (TNI)
    01 October 2006

    Based on two studies carried out in the cities of Buenos Aires and Montevideo, this report examines the origin, characteristics and impact of the explosive increase in cocaine base paste in urban areas. It also highlights the variety of products consumed in these cities and the substance known as crack that is consumed in Brazilian cities. The Brazilian experience with this consumption could serve as an example and a lesson for the Southern Cone.

     

  4. The 2006 World Drug Report: winning the war on drugs?

    01 September 2006

    This briefing paper looks at the issues raised by the publication in June of the latest World Drug Report by the United Nations Office on Drugs and Crime. The briefing paper analyses the developing data collection methodologies used by the UNODC and, while recognising their limitations, summarises the findings of the 2006 report on trends in the demand and supply of the main types of internationally prohibited drugs.

     

  5. International Drug Control: 100 Years of Success?

    26 June 2006
    Policy briefing

    In its 2006 World Drug Report, the UN Office on Drugs and Crime (UNODC) struggles to construct success stories to convince the world that the global drug control regime has been an effective instrument. An escape-route used in this year's World Drug Report is to fabricate comparisons with higher opium production levels a century ago and with higher prevalence figures for tobacco.

     

  6. A cannabis pandemic?

    26 June 2006
    Article

    In its 2006 World Drug Report, the UN Office on Drugs and Crime (UNODC) struggles to construct success stories to convince the world that the global drug control regime has been an effective instrument. UNODC Executive Director, Antonio Maria Costa claims that the world is experiencing a devastating “cannabis pandemic”. His strong language is at odds with other sections of the report, TNI commented in a press release.

  7. Study finds no cancer-marijuana connection

    25 May 2006
    Other news

    The largest study of its kind has unexpectedly concluded that smoking marijuana, even regularly and heavily, does not lead to lung cancer. The new findings "were against our expectations," said Donald Tashkin of the University of California at Los Angeles, a pulmonologist who has studied marijuana for 30 years. Marijuana also contains the chemical THC, which he said may kill aging cells and keep them from becoming cancerous.

  8. Review of the UK’s Drugs Classification System

    • Crime, Drug Strategy Directorate
    01 May 2006

    The UK system of classifying drugs according to their harmfulness has been in place since the introduction of the Misuse of Drugs Act in 1971. Over the past 35 years patterns of drug use have changed quite significantly, and recent debates about the classification of certain drugs, especially cannabis, have led to questions about the clarity of the current system and whether it remains fit for purpose.

     

  9. Coca Yes, Cocaine No?

    • Pien Metaal, Martin Jelsma, Ricardo Soberon, Mario Argandoña, Anthony Henman, Ximena Echeverría
    01 May 2006
    Report

    A decade-old demand to remove the coca leaf from strict international drugs controls has come to the fore again. Time has come to repair an historical error responsible for including the leaf amongst the most hazardous classified substances, causing severe consequences for the Andean region.

     

  10. The UNGASS Evaluation Evaluated

    • Tom Blickman, David Bewley-Taylor
    01 May 2006

    At the 49th Session of the Commission on Narcotic Drugs (CND), held in Vienna in March 2006, a draft resolution was tabled by the European Union (EU) to guide the process of evaluation of the implementation of political declaration and action plans of the 1998 UN General Assembly Special Session (UNGASS) in 2008. This briefing describes the fortunes of the resolution and its proposals to strengthen the upcoming UNGASS evaluation process. It explores how the resolution’s aims for more objective and transparent assessment were ultimately watered down. This was a result not only of opposition from states wary of transparency, objectivity and a possible re-evaluation of some current UN policies, but also the EU’s own approach to operating at the CND.

     

  11. Mandatory Minimum Sentences for Drug Offences

    01 April 2006

    The use of illegal drugs is often associated with a wide range of health, social and community problems, substantial drug-related crime, and stigma and marginalization of people who use drugs. In response, policy-makers have relied heavily on law enforcement, despite evidence that certain law enforcement practices actually worsen the impact of drug use on individuals and communities, and sometimes lead to human rights violations.

     

  12. Beyond Punitive Prohibition

    • Melissa T. Aoyagi
    01 March 2006

    The primary objective of this paper is to evaluate whether the drug conventions permit states to experiment with alternatives to the punitive prohibitionist policies that have typified the global approach to combating the negative effects of personal drug use. Because harm minimization encompasses most policies providing alternatives to punitive prohibition, the analysis that follows will focus on comparing the two strategies, in an effort to frame the current debate on drug policy.

     

  13. "Achterdeur open U"

    • Martin Jelsma
    09 February 2006

    Het Nederlandse cannabisbeleid verkeert al decennia in een internationaalrechtelijke schemerzone, stelt Martin Jelsma van het Transnational Institute (TNI). Nederland gedoogt de verkoop van kleine hoeveelheden softdrugs in coffeeshops (de zogenaamde voordeur), maar de aanvoer ervan (de achterdeur) is tot dusver verboden. In de loop der jaren is hierdoor een omvangrijke illegale sector ontstaan in Nederland die de coffeeshops bevoorraadt met nederwiet. Een kamermeerderheid wil nu het gedoogbeleid uitbreiden door een experiment met een gereguleerde aanvoer van wiet aan de achterdeur van coffeeshops, maar het kabinet is tegen.

  14. Legislating for Health and Human Rights

    01 January 2006

    The widespread legal, social and political ramifications of the HIV/AIDS epidemic make it necessary to review and reform a broad range of laws. Some countries have adopted national HIV/AIDS laws, but these laws often ignore crucial policy issues, as well as human rights abuses that perpetuate the HIV epidemic. This is particularly true with respect to illegal drug use.

     

  15. A tale of two cannabinoids

    • Ethan Russo, Geoffrey W. Guy
    01 January 2006

    This study examines the current knowledge of physiological and clinical effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their combination in pharmaceutical preparations. Cannabinoid and vanilloid receptor effects as well as non-receptor mechanisms are explored, such as the capability of THC and CBD to act as anti-inflammatory substances independent of cyclo-oxygenase (COX) inhibition. CBD is demonstrated to antagonise some undesirable effects of THC including intoxication, sedation and tachycardia, while contributing analgesic, anti-emetic, and anti-carcinogenic properties in its own right.